F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it. By Sharon LaFraniere and Noah Weiland from NYT U.S. https://ift.tt/3r38xEC